ArticleCurrent drug safety2024

Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors: Evaluation of Adverse Drug Reaction Reports.

Atul Khurana et al.PubMed ↗Publisher ↗

No numbers read from the abstract.